Share chart Pliant Therapeutics, Inc.
Extended chart
Simple chart
About Pliant Therapeutics, Inc.
Pliant Therapeutics, Inc., биофармацевтическая компания, работающая на клинической стадии, обнаруживает, разрабатывает и коммерциализирует новые методы лечения фиброза и связанных с ним заболеваний в Соединенных Штатах. Ведущим кандидатом на продукт является PLN-74809, низкомолекулярный двойной селективный ингибитор интегринов avß6 и avß1 для перорального применения, который находится в фазе II, отслеживается однократная возрастающая доза / многократная возрастающая доза, и завершены испытания фазы Ib с доказательством наличия механизма. more details| IPO date | 2020-06-03 |
|---|---|
| ISIN | US7291391057 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Сайт | http://pliantrx.com |
| Цена ао | 1.47 |
| Change price per day: | -7.01% (1.57) |
|---|---|
| Change price per week: | 0% (1.46) |
| Change price per month: | -0.6803% (1.47) |
| Change price per 3 month: | -86.63% (10.92) |
| Change price per half year: | -90.17% (14.86) |
| Change price per year: | -87.64% (11.81) |
| Change price per 3 year: | -67.26% (4.46) |
| Change price per year to date: | -88.91% (13.17) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Deep Track Capital, LP | 5750000 | 9.55 |
| Blackrock Inc. | 4801517 | 7.97 |
| FMR, LLC | 3963418 | 6.58 |
| Price (T.Rowe) Associates Inc | 3785916 | 6.28 |
| First Light Asset Management, LLC | 3591776 | 5.96 |
| Laurion Capital Management, LP | 3583567 | 5.95 |
| Vanguard Group Inc | 3065869 | 5.09 |
| Blue Owl Capital Holdings LP | 3004199 | 4.99 |
| Redmile Group, LLC | 2696648 | 4.48 |
| TRV GP IV, LLC | 2132867 | 3.54 |
| ETF | Share, % | Profitability for 1 year, % | Dividends, % |
|---|---|---|---|
| Future Tech ETF | 0.07066 | 426.34 | 0.8416 |
| Principal Healthcare Innovators ETF | 0.07066 | 618.5 | 0.8416 |
| iShares Morningstar Small-Cap Value ETF | 0.0158 | 197.28 | 2.50476 |
| iShares Morningstar Small-Cap ETF | 0.01142 | 391.25 | 1.60498 |
| iShares Morningstar Small-Cap Growth ETF | 0.00756 | 596.94 | 0.72598 |
| 0.04 | 446.06 | 1.3 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Johannes P. Hull | Chief Business Officer | 631.64k | 1975 (50 years) |
| Dr. Rik Derynck | Scientific Founder & Member of Scientific Advisory Board | N/A | |
| Mr. Dean Sheppard M.D. | Scientific Founder & Member of Scientific Advisory Board | N/A | |
| Mr. Bill DeGrado Ph.D. | Scientific Founder & Member of Scientific Advisory Board | N/A | |
| Mr. Hal Chapman M.D. | Scientific Founder & Member of Scientific Advisory Board | N/A | |
| Dr. Keith Lamont Cummings M.B.A., M.D. | Chief Financial Officer | 662.34k | 1977 (48 years) |
| Mr. Craig D. Muir | Interim Chief Technology Officer | N/A | |
| Mr. Mike Ouimette J.D. | General Counsel & Corporate Secretary | 591.05k | 1973 (52 years) |
| Dr. Bernard Coulie M.B.A., M.D., Ph.D. | President, CEO & Director | 1.06M | 1967 (58 years) |
| Dr. Eric A. Lefebvre M.D. | Chief Medical Officer | 1964 (61 year) |
Address: United States, South San Francisco, 260 Littlefield Avenue - open in Google maps, open in Yandex maps
Website: http://pliantrx.com
Website: http://pliantrx.com
